Episode #63: Canadian AF guidelines updated; Mark Midei, facing lawsuits, sues hospital himself; BP testing at black-owned barbershops; searchable "doctor-dollars" database; obesity drug dilemma

This feature requires the newest version of Flash. You can download it here.

For the week ending October 29, 2010 we discuss the following top cardiology news from heartwire :

• Canadian update to the AF guidelines: Role for dabigatran already in place

• Embattled Mark Midei speaks: Meets lawsuits by filing his own in "unnecessary-stenting" saga

• Barbershops a cut above for BP checks in African American men

• Searchable "doctor-dollars" database lists big pharma payments to cardiologists

• Diet drug dilemma: If CVD drops tomorrow are risks justified today?

And also, in brief:

• CYP2C19 loss-of-function gene ups risk of events post-PCI: New meta-analysis

• High heart rate linked with increased mortality in stable coronary heart disease

• Double-dose clopidogrel helpful for some patients with high platelet reactivity on normal dose

• Obesity drug lorcaserin rejected by FDA

Join us for a comprehensive review of this week’s most important cardiology news.

Cite this: Episode #63: Canadian AF guidelines updated; Mark Midei, facing lawsuits, sues hospital himself; BP testing at black-owned barbershops; searchable "doctor-dollars" database; obesity drug dilemma - Medscape - Oct 29, 2010.